K. Karthikeyan et al. / Tetrahedron Letters 50 (2009) 7175–7179
7179
Fishwick, C. W. G.; Grigg, R.; Kilner, C. Tetrahedron 2004, 60, 3473; (i) Wittland,
C.; Florke, U.; Risch, N. Synthesis 1997, 1291; (j) Dondoni, A.; Marra, A.
Tetrahedron Lett. 2002, 43, 1649.
104.9, 110.8, 124.7, 125.5, 126.4, 126.5, 126.7, 126.8, 126.9, 127.2, 127.3, 130.1,
133.2, 135.1, 155.0, 168.8, 172.9, 173.2; ESI-MS (LCQ) m/z = 581 M++1. Anal.
Calcd for C34H32N2O7 (580.22): C, 70.33; H, 5.56; N, 4.82. Found: C, 70.50; H,
5.52; N, 4.76.
8. (a) Elbein, A. D.; Molyneux, R. J. In Iminosugars as Glycosidase Inhibitors;
Nojirimycin and Beyond; Stütz, A. E., Ed.; Wiley-VCH: Weinheim, 1999; pp 216–
251; (b) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron:
Asymmetry 2000, 11, 1645; (c) Greimel, P.; Spreitz, J.; Stutz, A. E.; Wrodnigg, T.
M. Curr. Top. Med. Chem. 2003, 11, 513; (d) Fiaux, H.; Popowycz, F.; Favre, S.;
Schütz, C.; Vogel, P.; Gerber-Lemaire, S.; Juillerat-Jeanneret, L. J. Med. Chem.
2005, 48, 4237; (e)Pharmaceuticals; McGuire, J. L., Ed.; Wiley-VCH: Weinheim,
2000; Vols. 1–4.
9. (a) Dwek, R. A. Chem. Rev. 1996, 96, 683; (b) Rudd, P. M.; Elliott, T.; Cresswell,
P.; Wilson, I. A.; Dwek, R. A. Science 2001, 291, 2370; (c)Glycoscience: Chemistry
and Chemical Biology; Fraser Reid, B., Tatsuta, K., Thiem, J., Eds.; Springer:
Heidelberg, 2001; (d) Varki, A. Glycobiology 1993, 3, 97; (e) Hotha, S.; Kashyap,
S. J. Am. Chem. Soc. 2006, 128, 9620.
10. Carbohydrate Based Drug Discovery; Wong, C.-H., Ed.; Wiley-VCH: Weinheim,
2003.
11. (a) Karthikeyan, K.; Perumal, P. T.; Etti, S.; Shanmugam, G. Tetrahedron 2007,
63, 10581; (b) Karthikeyan, K.; Seelan, T. V.; Lalitha, K. G.; Perumal, P. T. Bioorg.
Med. Chem. Lett. 2009, 19, 3370.
12. Wolform, M. L.; Hanessian, S. J. Org. Chem. 1962, 27, 1800.
13. The required secondary amines 2a–b were prepared by the reaction of
benzylamine with ethyl or benzyl bromoacetate in the presence of
diisopropylethylamine in dichloromethane under reflux.
14. For endo-selective 1,3-dipolar cycloaddition see: (a) Enders, D.; Meyer, I.;
Runsink, J.; Raabe, G. Tetrahedron 1998, 54, 10733; (b) Anslow, A. S.; Harwood,
L. M.; Phillips, H.; Watkin, D.; Wong, L. F. Tetrahedron: Asymmetry 1991, 2,
1343; (c) Harwood, L. M.; Lilley, I. A. Tetrahedron: Asymmetry 1995, 6, 1557; (d)
Cabrera, S.; Arrayás, R. G.; Martín-Matute, B.; Cossío, F. P.; Carretero, J. C.
Tetrahedron 2007, 63, 6587.
endo 6g: Colourless solid; mp 60–62 °C; Rf = 0.56 (50% ethylacetate/petroleum
ether); IR (cmꢀ1): 2984, 1719, 1659, 1495, 1378, 1196, 1040; ½a 3D1
ꢁ
+152.9 (0.42,
CHCl3); 1H NMR (500 MHz, CDCl3): d 1.43 (s, 3H), 1.60 (s, 3H), 3.45 (dd, 1H,
J = 8.4, 1.6 Hz, H-3a), 3.53 (d, 1H, J = 13.0 Hz, –NCHH), 3.82 (t, 1H, J = 8.4 Hz, H-
6a), 3.91 (d, 1H, J = 13.8 Hz, –NCHH), 4.23 (d, 1H, J = 1.5 Hz, H-3), 4.37 (d, 1H,
J = 8.4 Hz, H-1), 5.11 (s, 2H), 5.17 (d, 1H, J = 2.3 Hz, H-30), 5.24 (dd, 1H, J = 5.4,
2.3 Hz, H-20), 6.07 (d, 1H, J = 5.4 Hz, H-10), 7.21–7.25 (m, 7H, Ar–H), 7.32–7.34
(m, 4H, Ar–H), 7.39 (t, 2H, J = 6.9 Hz, Ar–H), 7.45 (d, 2H, J = 7.7 Hz, Ar–H); 13C
NMR (100 MHz, CDCl3): d 27.5, 28.4, 47.3, 48.3, 51.7, 59.3, 66.1, 67.5, 82.9,
103.5, 106.7, 112.4, 126.6, 127.4, 128.4, 128.5, 128.6, 128.7, 128.9, 129.1, 129.2,
131.9, 135.1, 137.3, 158.4, 170.3, 175.2, 175.9; ESI-MS (LCQ) m/z = 581 M++1.
Anal. Calcd for C34H32N2O7 (580.22): C, 70.33; H, 5.56; N, 4.82. Found: C, 70.52;
H, 5.59; N, 4.88.
exo 7g: Less amount of endo 8g was present; viscous liquid; Rf = 0.59 (50%
ethylacetate/petroleum ether); IR (cmꢀ1): 2989, 1718, 1660, 1497, 1375, 1196,
1045; ½a 2D6
ꢁ
ꢀ57.5 (0.64, CHCl3); 1H NMR (500 MHz, CDCl3): d 1.39 (s, 3H), 1.48
(s, 3H), 3.43 (d, 1H, J = 8.4 Hz, CH-6a), 3.52 (d, 1H, J = 13.8 Hz, –NCHH), 3.77 (t,
1H, J = 9.2 Hz, H-3a), 4.02 (d, 1H, J = 12.3 Hz, –NCHH), 4.23 (s, 1H, H-1), 4.41 (d,
1H, J = 9.2 Hz H-3), 5.09 (d, 1H, J = 12.3 Hz), 5.15 (dd, 1H, J = 5.4, 2.3 Hz, H-20),
5.25 (d, 1H, J = 12.3 Hz), 5.33 (d, 1H, J = 2.3 Hz, H-30), 6.02 (d, 1H, J = 5.4 Hz, H-
10), 7.07–7.08(m, 2H, Ar–H), 7.21–7.24 (m, 3H, Ar–H), 7.29 (d, 2H, J = 7.7 Hz,
Ar–H), 7.34–7.41(m, 6H, Ar–H), 7.47 (t, 2H, J = 7.7 Hz, Ar–H); 13C NMR
(100 MHz, CDCl3): d 27.6, 27.8, 47.7, 48.5, 52.1, 61.4, 63.3, 66.8, 82.7, 100.7,
106.6, 112.7, 126.4, 127.8, 128.3, 128.5, 128.6, 128.7, 128.8, 129.1, 129.2, 131.9,
135.1, 137.1, 159.1, 170.6, 174.0, 175.1; ESI-MS (LCQ) m/z = 581 M++1. Anal.
Calcd for C34H32N2O7 (580.22): C, 70.33; H, 5.56; N, 4.82. Found: C, 70.42; H,
5.63; N, 4.72.
15. For metalcatalyzed exo-selective 1,3-dipolar cycloaddition see: (a) Peddibhotla,
S.; Tepe, J. J. J. Am. Chem. Soc. 2004, 126, 12776; (b) Oderaotoshi, Y.; Cheng, W.;
Fujitomi, S.; Kasano, Y.; Ninakata, S.; Komatsu, M. Org. Lett. 2003, 5, 5043; (c)
Ayerbe, M.; Arrieta, A.; Cossio, F. P. J. Org. Chem. 1998, 63, 1795.
16. Experimental procedure for compounds 5–8: A mixture of 3-O-benzyl-1,2-O-
isopropylidene-xylopentadialdose 1a (1.08 mmol), N-benzyl glycine ethyl or
endo 8g: Colourless solid; mp 138–140 °C; Rf = 0.65 (50% ethylacetate/
petroleum ether); IR (cmꢀ1): 2984, 1718, 1662, 1495, 1385, 1190, 1044;
½ ꢁ
a 3D0 +93.2 (0.60, CHCl3); 1H NMR (500 MHz, CDCl3): d 1.43 (s, 6H), 3.41
(d, 1H, J = 13.0 Hz, –NCHH), 3.45 (dd, 1H, J = 8.5, 1.6 Hz, H-3a), 3.84 (d, 1H,
J = 13.0 Hz, –NCHH), 3.86 (t, 1H, J = 8.4 Hz, H-6a), 4.25 (d, 1H, J = 2.3 Hz, H-3),
4.37 (d, 1H, J = 9.2 Hz, H-1), 5.09–5.16 (m, 3H), 5.31 (dd, 1H, J = 5.4, 2.3 Hz, H-
20), 6.07 (d, 1H, J = 5.4 Hz, H-10), 7.22–7.26(m, 7H, Ar–H), 7.32–7.37 (m, 5H,
Ar–H), 7.41 (d, 1H, J = 6.9 Hz, Ar–H), 7.45 (t, 2H, J = 7.6 Hz, Ar–H); 13C NMR
(100 MHz, CDCl3): d 27.8, 28.5, 29.7, 47.4, 51.9, 59.5, 66.3, 67.5, 83.1, 103.9,
106.2, 112.3, 126.7, 127.5, 128.3, 128.4, 128.5, 128.6, 128.8, 129.0, 129.2,
131.8, 135.1, 137.3, 157.0, 170.3, 175.3, 175.9; ESI-MS (LCQ) m/z = 581 M++1.
Anal. Calcd for C34H32N2O7 (580.22): C, 70.33; H, 5.56; N, 4.82. Found: C,
70.22; H, 5.52; N, 4.87.
benzyl ester
2 (1.29 mmol) and N-aryl/alkyl maleimide 3 (1.29 mmol) in
toluene (15 ml) was refluxed for 3 h. After completion of the reaction, the
solvent was evaporated under reduced pressure and the products 5–8 were
separated by flash column chromatography using silica gel (230–400 mesh)
with ethyl acetate: petroleum ether as an eluent.
2-Benzyl-3-(2,2-dimethyl-3a,6a-dihydro-furo[2,3-d][1,3]dioxol-5-yl)-4,6-dioxo-5-
phenyl-octahydro-pyrrolo[3,4-c]pyrrole-1-carboxylic acid benzyl ester (5g, 6g, 7g,
8g): Yield: 0.451 g (72%):exo 5g: Colourless solid; mp 63–65 °C; Rf = 0.54 (50%
ethylacetate/petroleum ether); IR (cmꢀ1): 2981, 1717, 1657, 1498, 1384, 1192,
17. Crystallographic data for the structure 5c in this Letter have been deposited
with the Cambridge Crystallographic Data centre as supplemental Publication
No. CCDC-689250. Copies of the data can be obtained, free of charge on
application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44 01223
336033 or email: deposit@ccdc.cam.ac.uk).
18. Crystallographic data for the structure 8c in this Letter have been deposited
with the Cambridge Crystallographic Data centre as supplemental Publication
No. CCDC-699267. Copies of the data can be obtained, free of charge on
application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44 01223
336033 or email: deposit@ccdc.cam.ac.uk).
1045; ½a 3D0
ꢁ
ꢀ37.9 (1.18, CHCl3); 1H NMR (500 MHz, CDCl3): d 1.38 (s, 3H), 1.39
(s, 3H), 3.41 (d, 1H, J = 8.4 Hz, H-6a), 3.48 (d, 1H, J = 13.0 Hz, ꢀNCHH), 3.59 (t,
1H, J = 8.4 Hz, H-3a), 3.94 (d, 1H, J = 13.0 Hz, ꢀNCHH), 4.16 (s, 1H, H-1), 4.47 (d,
1H, J = 9.2 Hz, H-3), 5.10 (d, 1H, J = 11.5 Hz), 5.19 (dd, 1H, J = 5.4, 2.3 Hz, H-20),
5.25 (d, 1H, J = 12.3 Hz), 5.47 (d, 1H, J = 2.3 Hz, H-30), 5.87 (d, 1H, J = 5.4 Hz, H-
10), 7.12–7.14(m, 2H, Ar–H), 7.21–7.22 (m, 3H, Ar–H), 7.32 (d, 2H, J = 7.7 Hz,
Ar–H), 7.35–7.43(m, 6H, Ar–H), 7.50 (t, 2H, J = 7.7 Hz, Ar–H); 13C NMR
(100 MHz, CDCl3): d 25.6, 26.0, 45.4, 46.6, 49.6, 59.2, 60.7, 64.8, 80.8, 102.7,